Biotech company Biogen lowered its full-year profit forecast, citing higher costs related to its purchase of drug maker Reata Pharmaceuticals as well as the launch of its Alzheimer's drug.
Share:
More In Business
Ford Suspends Construction of Battery Plant
Ford Suspends Construction of Battery Plant
JPMorgan Chase Settles $75M Epstein Sex Trafficking Lawsuit
JPMorgan Chase Settles $75M Epstein Sex Trafficking Lawsuit
Amazon Faces Antitrust Charges From FTC, U.S. States
Amazon Faces Antitrust Charges From FTC, U.S. States
Stretching Your Dollar: Expert Advice on Financial Etiquette
Learning how to properly navigate the world of money
Stretching Your Dollar: How A Government Shutdown Could Impact Your Finances
A government shutdown could have an impact on your personal finances, particularly for federal employees.
Survey Shows Many Americans Changed Their Line of Work
A swath of Americans switched careers in recent years but how much did the COVID-19 pandemic impact those decisions?
Legit Cannabis Dealers Face Counterfeit Website Dilemma
Legal cannabis dealers are navigating the industry as counterfeit websites trend.
Amazon Sued by FTC and 17 States Over Allegations it Inflates Online Prices and Overcharges Sellers
Amazon is being sued by U.S. regulators and and 17 states over allegations that the company abuses its position in the marketplace to inflate prices on other platforms, overcharge sellers and stifle competition.
Government Shutdown Could Hurt U.S. Credit Rating
Government Shutdown Could Hurt U.S. Credit Rating
